Skip to main content

Day: May 23, 2023

Viral Clearance Market Size to Surpass USD 1,867.5 million by 2030, exhibiting a CAGR of 17.0%

As per the report by Fortune Business Insights, the global Viral Clearance Market size is projected to reach USD 1,867.5 million by 2030, at a CAGR of 17.0% during the forecast period, 2023-2030 Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Viral Clearance Market size was valued at USD 539.6 million in 2022 and is projected to grow from USD 621.1 million in 2023 to USD 1,867.5 million by 2030, exhibiting a CAGR of 17.0% during the forecast period. Viral clearance is crucial in manufacturing biosimilar, stem cell products, biopharmaceuticals, antibodies, and others. Robust investments in biotechnology are expected to boost the clearance’s adoption. Furthermore, increasing investments in pharmaceutical products may foster industry development. Moreover, the rising research and development...

Continue reading

Viral Vaccines Market Size to Surpass USD 74.25 billion by 2029, exhibiting a CAGR of 2.7%

As per the report by Fortune Business Insights, the global Viral Vaccines Market size is projected to reach USD 74.25 billion by 2029, at a CAGR of 2.7% during the forecast period, 2022-2029 Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Viral Vaccines Market size was valued at USD 90.02 billion in 2021 and is projected to grow from USD 89.90 billion in 2022 to USD 74.25 billion by 2029, exhibiting a CAGR of 2.7% during the forecast period. One of the most effective prevention measures for viral infections is viral vaccines. Viral infections cause several diseases, such as the flu and warts, common cold, and other severe diseases, including Ebola, human immunodeficiency virus (HIV/ AIDS), COVID-19, and influenza. Some viruses that need seasonal and geographical variation for their growth...

Continue reading

Q1, 2023

To Nasdaq OMX Copenhagen A/S Public announcement no. 544May 23rd, 2023 ECONOMIC KEY FIGURES FOR GLUNZ & JENSEN HOLDING A/S Q1 2023 The Q1, 2023 (January through March 2023) of the fiscal year was reviewed and approved at the Board of Directors meeting today. The Board of Directors announces the following consolidated financial statement year to date (YTD) for Q1 (January through March) of 2023. The Q1 result for the fiscal year 2023 has met the expectations. HighlightsThe revenue for YTD Q1 2023 amounted to DKK 40.5 million (2022: DKK 34.1 million). EBITDA for the period was DKK 6.4 million (2022: DKK 4.8 million). Profit before tax for the period was DKK 4.9 million (2022: DKK 2.0 million).Glunz & Jensen has delivered a strong Q1, 2023 despite continued supply challenges of manufacturing parts. Glunz & Jensen maintains...

Continue reading

Kineta to Present at Jefferies Healthcare Conference

SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that Shawn Iadonato, Ph.D., Chief Executive Officer at Kineta, will present at the Jefferies Healthcare Conference, being held in New York, NY from June 7-9, 2023. Company management will also be available for one-on-one meetings. Event: Jefferies Healthcare ConferenceLocation: New York, NYDate:   Friday June 9, 2023Time: 10:00-10:25 A.M. Eastern Time The webcast presentation will be available for viewing and replay on the Events & Presentations section of the Company’s website. About KinetaKineta (Nasdaq: KA) is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies...

Continue reading

Verve Therapeutics to Participate in the Stifel 2023 Tailoring Genes: Virtual Genetic Medicines Day

BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer, will participate in a fireside chat during the Stifel 2023 Tailoring Genes: Virtual Genetic Medicines Day on Tuesday, May 30, 2023 at 4:10 p.m. ET. A live webcast will be available in the investor section of the company’s website at www.vervetx.com. The webcast will be archived for 30 days following the presentation. About Verve Therapeutics Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage genetic medicines company pioneering a new approach to the care of cardiovascular disease, potentially transforming treatment from chronic...

Continue reading

Affimed Reports First Quarter 2023 Financial Results and Highlights Operational Progress

AFM13 combination with AB-101 NK cells: Received IND clearance from the FDA for a phase 2 clinical trial investigating the combination therapy in relapsed/refractory (r/r) classical Hodgkin Lymphoma (cHL) and peripheral T Cell Lymphoma (PTCL). Affimed expects to initiate clinical trial in Q3 2023 and report initial data in H1 2024 AFM24 monotherapy: Data from non-small cell lung cancer (NSCLC) expansion cohort accepted for poster presentation; data from colorectal cancer (CRC) cohort accepted for online publication at the American Society of Clinical Oncology (ASCO) 2023 meeting AFM24 combinations: Data from the combinations with atezolizumab and SNK01 expected to be presented in H2 2023 AFM28: Cleared first dose cohort without dose limiting toxicities in first-in-human monotherapy dose escalation study in patients with CD123-positive...

Continue reading

Construction Equipment Rental Market Size Expected to Reach USD 164.6 Billion in 2029 | Loxam Group Acquired JM Trykluft A/S to Reinforce Industry Presence

Construction Equipment Rental Market to Grow at 5.1% CAGR from 2022 to 2029; Earthmoving Solutions to Record Commendable Surge Due to Increasing Road Infrastructure Activities Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — The global construction equipment rental market size was USD 111.6 billion in 2021. The industry is anticipated to surge from USD 116.0 billion in 2022 to USD 164.6 billion in 2029, exhibiting a CAGR of 5.1% from 2022 to 2029. The rise can be credited to the escalating presence of local and regional businesses and their growing inclination toward the achievement of flexibility and revenue generation. This information is provided by Fortune Business Insights™ in its research report, titled “Construction Equipment Rental Market, 2022-2029”. Construction Equipment Rental Market Report Key Insights: Construction...

Continue reading

Interim report of Copenhagen Airports A/S (CPH) for the period 1 January – 31 March 2023

The Board of Directors has today approved the interim report for the period 1 January – 31 March 2023.COPENHAGEN AIRPORTS A/S P.O. Box 74 Lufthavnsboulevarden 6 DK-2770 KastrupContact: Rasmus Lund CFOTelephone: +45 3231 3231 Email: cphpresse@cph.dk www.cph.dk CVR nr. 14 70 72 04  AttachmentQ1 Report of Copenhagen Airports A-S

Continue reading

Micro Electric Vehicles Market Size Expected to Reach USD 22.11 Billion in 2029 | Development of Ultra-Capacitors to Drive the Market Growth

Micro Electric Vehicle Market to Exhibit a CAGR of 12.7% between 2022 and 2029; Favorable Government Regulations to Fuel Market Growth Pune, India., May 23, 2023 (GLOBE NEWSWIRE) — The global micro electric vehicle market size is predicted to reach USD 22.11 billion by 2029 and exhibit a CAGR of 12.7% during the projected period. Fortune Business InsightsTM has presented this information in its report titled, “Micro Electric Vehicle Market, 2022-2029”. The market stood at USD 8.32 billion in 2021 and USD 9.57 billion in 2022. Micro Electric Vehicle Market Report Key Insights: Micro Electric Vehicle market research report provides you comprehensive and insightful information about Micro Electric Vehicle industry. This report is a valuable tool for businesses, investors, and decision-makers to understand market dynamics, assess opportunities,...

Continue reading

Organic Solar Cell Market Size Expected to Reach USD 101.29 Million in 2027 | High Demand for Electricity to Aid Growth

Organic Solar Cell Market worth 12.30% CAGR; Generation of Power Using Renewable Resources in Asia Pacific to Propel Growth, states Fortune Business Insights™ Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — The global organic solar cell market is set to gain impetus from the rapid infrastructure development and increasing population growth. It would propel the demand for electricity worldwide. This information is given by Fortune Business Insights™ in a new report, titled, “Organic Solar Cell Market Size, Share and COVID-19 Impact Analysis By Application (Building Integrated Photovoltaic {BIPV}, Portable Electronics, Defense Application, Conventional Solar, and Others), and Regional Forecast, 2020-2027.” The report further states that the organic solar cell market size was USD 55.63 million in 2019. It is projected...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.